Senior Management

Learn More

Board of Directors

Learn More

Clinical Advisory Board

Learn More

Scientific Advisory Board

Learn More

Bexion Milestones

Bexion at a glance data

Making Significant Progress

Bexion at a glance data

Bexion Media

PRESS RELEASE

Bexion Pharmaceuticals Presenting BXQ-350 Data at ASCO 2020
May 13, 2020

For Immediate Release, Covington, KY May 13, 2020 Bexion Pharmaceuticals announced today that the following three abstracts submitted to the 2020 American Society of Clinical Oncology (ASCO) have been accepted for oral or poster presentation: Oral Presentation Tolerability and preliminary efficacy of BXQ-350 for refractory solid tumors and high-grade gliomas: First-in-human, first-in-class phase I trial. […]

read more
All Press


Bexion Pharmaceuticals president and CEO Ray Takigiku Interviewed by Cincinnati Public Radio
May 22, 2019

Bexion Pharmaceuticals president and CEO Ray Takigiku was interviewed by Cincinnati Public Radio on May 22, 2019. Click here to read more and listen to the interview.

read more
Bexion In the News